benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]
benzoyl peroxide
RxCUI: 213082
What the CMS Formulary Data Shows for benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]
Per the CMS 2026 Part D formulary file, benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] (RxNorm concept RXCUI 213082, generic name benzoyl peroxide) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 465 Part D beneficiaries filled benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] in 2023, with total plan-and-beneficiary spending of $437,973 and an average per-beneficiary annual cost of $941.88. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 465
- Total spending
- $437,973
- Avg per beneficiary
- $941.88
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] covered by Medicare Part D?
Yes, benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] on Medicare Part D plans?
benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] require prior authorization?
0% of Part D formularies require prior authorization for benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]?
In 2023, total Medicare Part D spending on benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin] was $437,973, covering 465 beneficiaries. The average spend per beneficiary was $941.88.
Read our methodology - how this data is sourced, computed, and verified.